通过靶向LRIG2对miR-149-5p在黑色素瘤细胞存活和凋亡中的负调控作用
The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2.
作者信息
Chen Wenqi, Zhang Jinhai, Xu Huijuan, Dai Jie, Zhang Xiaorong
机构信息
Department of Dermatology, Nanjing First Hospital, Nanjing Medical UniversityNanjing, Jiangsu, China.
Department of Epidemiology, Research Institute for Medicine of Nanjing CommandNanjing, Jiangsu, China.
出版信息
Am J Transl Res. 2017 Sep 15;9(9):4331-4340. eCollection 2017.
Abstract
MicroRNAs (miRNAs) are key regulators of diverse biological processes in tumor progression including melanoma. LRIG2 is reported as an oncogene in cancer, however, little is known regarding the molecular and functions of LRIG2 in melanoma. In this study, we reported that LRIG2 expression was higher in melanoma tissues and cell lines and was regulated by miR-149-5p. Furthermore, a luciferase reporter assay and rescue experiment indicated that miR-149-5p directly targeted LRIG2 by binding its 3'UTR. The overexpression of miR-149-5p significantly suppressed melanoma cell proliferation, colony formation, and promoted cell apoptosis. These results suggest that miR-149-5p acts as a suppressing molecule and may be a good method for melanoma therapy.
摘要
微小RNA（miRNA）是肿瘤进展（包括黑色素瘤）中多种生物学过程的关键调节因子。LRIG2在癌症中被报道为一种癌基因，然而，关于LRIG2在黑色素瘤中的分子机制和功能知之甚少。在本研究中，我们报道LRIG2在黑色素瘤组织和细胞系中表达较高，且受miR-149-5p调控。此外，荧光素酶报告基因实验和拯救实验表明，miR-149-5p通过结合LRIG2的3'非翻译区直接靶向LRIG2。miR-149-5p的过表达显著抑制黑色素瘤细胞增殖、集落形成，并促进细胞凋亡。这些结果表明，miR-149-5p作为一种抑制分子，可能是黑色素瘤治疗的一种有效方法。
相似文献
1
The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2.
Am J Transl Res. 2017 Sep 15;9(9):4331-4340. eCollection 2017.
2
miR-142-5p enhances cisplatin-induced apoptosis in ovarian cancer cells by targeting multiple anti-apoptotic genes.
Biochem Pharmacol. 2019 Mar;161:98-112. doi: 10.1016/j.bcp.2019.01.009. Epub 2019 Jan 11.
3
[miR-122-5p inhibits the proliferation of melanoma cells by targeting NOP14].
Nan Fang Yi Ke Da Xue Xue Bao. 2018 Nov 30;38(11):1360-1365. doi: 10.12122/j.issn.1673-4254.2018.11.14.
4
MicroRNA-485-5p represses melanoma cell invasion and proliferation by suppressing Frizzled7.
Biomed Pharmacother. 2017 Jun;90:303-310. doi: 10.1016/j.biopha.2017.03.064. Epub 2017 Mar 30.
5
MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.
Am J Transl Res. 2016 Nov 15;8(11):4892-4901. eCollection 2016.
6
MicroRNA-7-5p induces cell growth inhibition, cell cycle arrest and apoptosis by targeting PAK2 in non-small cell lung cancer.
FEBS Open Bio. 2019 Nov;9(11):1983-1993. doi: 10.1002/2211-5463.12738. Epub 2019 Oct 24.
7
MiR-129-5p functions as a tumor suppressor in gastric cancer progression through targeting ADAM9.
Biomed Pharmacother. 2018 Sep;105:420-427. doi: 10.1016/j.biopha.2018.05.105. Epub 2018 Jun 4.
8
MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
World J Gastroenterol. 2016 Jun 21;22(23):5364-73. doi: 10.3748/wjg.v22.i23.5364.
9
Small Nucleolar RNA Host Gene 12 (SNHG12) Promotes Proliferation and Invasion of Laryngeal Cancer Cells via Sponging miR-129-5p and Potentiating WW Domain-Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Expression.
Med Sci Monit. 2019 Jul 26;25:5552-5560. doi: 10.12659/MSM.917088.
10
MiR-338-5p promotes the growth and metastasis of malignant melanoma cells via targeting CD82.
Biomed Pharmacother. 2018 Jun;102:1195-1202. doi: 10.1016/j.biopha.2018.03.075. Epub 2018 Apr 10.
引用本文的文献
1
Non-coding RNAs in BRAF-mutant melanoma: targets, indicators, and therapeutic potential.
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):297-317. doi: 10.1007/s00210-024-03366-3. Epub 2024 Aug 21.
2
Asymmetric and parallel subgenome selection co-shape common carp domestication.
BMC Biol. 2024 Jan 2;22(1):4. doi: 10.1186/s12915-023-01806-9.
3
Effect of miR-149-5p on intramuscular fat deposition in pigs based on metabolomics and transcriptomics.
BMC Genomics. 2023 May 31;24(1):293. doi: 10.1186/s12864-023-09382-6.
4
LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma.
BMC Cancer. 2022 Oct 1;22(1):1029. doi: 10.1186/s12885-022-10123-3.
5
Expression Profile of mRNAs and miRNAs Related to the Oxidative-Stress Phenomenon in the Ishikawa Cell Line Treated Either Cisplatin or Salinomycin.
Biomedicines. 2022 May 20;10(5):1190. doi: 10.3390/biomedicines10051190.
6
The potential role of circRNA_004229 in hair/epidermal regulation after MED1 ablation in keratinocytes.
RSC Adv. 2019 Jun 18;9(33):19095-19103. doi: 10.1039/c9ra02322d. eCollection 2019 Jun 14.
7
A Review on the Role of miR-149-5p in the Carcinogenesis.
Int J Mol Sci. 2021 Dec 30;23(1):415. doi: 10.3390/ijms23010415.
8
MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.
Front Oncol. 2021 Apr 22;11:608987. doi: 10.3389/fonc.2021.608987. eCollection 2021.
9
Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17.
Cancer Manag Res. 2021 Mar 25;13:2773-2783. doi: 10.2147/CMAR.S281968. eCollection 2021.
10
Circ-FOXM1 knockdown suppresses non-small cell lung cancer development by regulating the miR-149-5p/ATG5 axis.
Cell Cycle. 2021 Jan;20(2):166-178. doi: 10.1080/15384101.2020.1867780. Epub 2021 Jan 8.
本文引用的文献
1
MicroRNAs in melanoma development and resistance to target therapy.
Oncotarget. 2017 Mar 28;8(13):22262-22278. doi: 10.18632/oncotarget.14763.
2
Systems analysis identifies miR-29b regulation of invasiveness in melanoma.
Mol Cancer. 2016 Nov 16;15(1):72. doi: 10.1186/s12943-016-0554-y.
3
Multimodal tumor suppression by miR-302 cluster in melanoma and colon cancer.
Int J Biochem Cell Biol. 2016 Dec;81(Pt A):121-132. doi: 10.1016/j.biocel.2016.11.004. Epub 2016 Nov 10.
4
MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells.
Diabetes. 2017 Jan;66(1):100-112. doi: 10.2337/db16-0592. Epub 2016 Oct 13.
5
miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.
Curr Med Chem. 2016;23(28):3136-3153. doi: 10.2174/1389557516666160831164544.
6
MicroRNAs role as potential biomarkers and key regulators in melanoma.
Genes Chromosomes Cancer. 2017 Jan;56(1):3-10. doi: 10.1002/gcc.22402. Epub 2016 Oct 25.
7
miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.
Oncotarget. 2016 Aug 16;7(33):53558-53570. doi: 10.18632/oncotarget.10669.
8
MiR-330-5p regulates tyrosinase and PDIA3 expression and suppresses cell proliferation and invasion in cutaneous malignant melanoma.
J Surg Res. 2016 Jun 15;203(2):434-40. doi: 10.1016/j.jss.2016.03.021. Epub 2016 Mar 19.
9
miR-339-3p Is a Tumor Suppressor in Melanoma.
Cancer Res. 2016 Jun 15;76(12):3562-71. doi: 10.1158/0008-5472.CAN-15-2932. Epub 2016 Apr 15.
10
Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma.
Mol Med Rep. 2016 Jun;13(6):5386-92. doi: 10.3892/mmr.2016.5205. Epub 2016 Apr 28.
Zotero 插件